BELLUS Health Inc. (BLU)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.03+0.24 (+4.15%)
At close: 4:00PM EDT
5.98 -0.05 (-0.83%)
After hours: 05:36PM EDT
After hours: 05:36PM EDT
| Previous close | 5.79 |
| Open | 5.84 |
| Bid | 5.88 x 800 |
| Ask | 5.99 x 1400 |
| Day's range | 5.64 - 6.10 |
| 52-week range | 2.01 - 6.34 |
| Volume | 1,833,122 |
| Avg. volume | 1,812,301 |
| Market cap | 472.586M |
| Beta (5Y monthly) | -0.55 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.67 |
| Earnings date | 10 Nov 2021 - 15 Nov 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Implied Volatility Surging for BELLUS Health (BLU) Stock Options
Investors need to pay close attention to BELLUS Health (BLU) stock based on the movements in the options market lately.
- Business Wire
BELLUS Health Announces Positive Interim Analysis from the Phase 2b SOOTHE Trial of BLU-5937 in Refractory Chronic Cough
LAVAL, Quebec, September 13, 2021--BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) ("BELLUS Health" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory chronic cough and other hypersensitization-related disorders, today announced positive findings from a preplanned administrative interim analysis of the ongoing Phase 2b SOOTHE trial of BLU-5937, the Company’s highly selective P2X3 antagonist, in patients with refractory chronic cou
- Simply Wall St.
How Much Of BELLUS Health Inc. (TSE:BLU) Do Institutions Own?
If you want to know who really controls BELLUS Health Inc. ( TSE:BLU ), then you'll have to look at the makeup of its...
© 2021 Verizon Media. All rights reserved.
